Jama Cardiol

• 

  Publication Venue For

  • Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) Registry. 2020
  • Influence of Clinical Trials of Acute Coronary Syndrome Beyond the Primary Hypothesis: A Systematic Review..  5:1286-1297. 2020
  • Antithrombotic Strategies in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention-Reply. 2020
  • Should We Simplify Computed Tomography Angiography Reporting as Black or White vs Describing All Shades of Gray?-Reply. 2020
  • Quality of Care and Outcomes Among Medicare Advantage vs Fee-for-Service Medicare Patients Hospitalized With Heart Failure. 2020
  • Geographic Access to Transcatheter Aortic Valve Replacement Centers in the United States: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry..  5:1006-1010. 2020
  • Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial..  5:757-764. 2020
  • Association Between Visit-to-Visit Blood Pressure Variability in Early Adulthood and Myocardial Structure and Function in Later Life..  5:795-801. 2020
  • Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial..  5:773-786. 2020
  • Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction..  5:765-772. 2020
  • Geographic Access to Transcatheter Aortic Valve Replacement Centers in the United States: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 2020
  • Functional vs Anatomical Testing for Patients With Stable Chest Pain-Binary or Directional Thinking? 2020
  • Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure..  5:643-651. 2020
  • The Conundrum and Opportunity of Gender Equity for Evidence Generators..  5:623-624. 2020
  • Transplant Center Variability in Organ Offer Acceptance and Mortality Among US Patients on the Heart Transplant Waitlist..  5:660-668. 2020
  • Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes..  5:703-708. 2020
  • Association Between Delays in Mechanical Ventilation Initiation and Mortality in Patients With Refractory Cardiogenic Shock. 2020
  • Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals. 2020
  • Performance Metrics to Improve Quality in Contemporary Percutaneous Coronary Intervention Practice. 2020
  • Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19). 2020
  • Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS Trial..  5:532-539. 2020
  • Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation. 2020
  • Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis..  5:582-589. 2020
  • Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial..  5:598-607. 2020
  • Association of Blood Pressure Patterns in Young Adulthood With Cardiovascular Disease and Mortality in Middle Age..  5:382-389. 2020
  • Effects of a 9-Week Hybrid Comprehensive Telerehabilitation Program on Long-term Outcomes in Patients With Heart Failure: The Telerehabilitation in Heart Failure Patients (TELEREH-HF) Randomized Clinical Trial..  5:300-308. 2020
  • Patient Perceptions and Familiarity With Medical Therapy for Heart Failure..  5:292-299. 2020
  • Age-Related Differences in the Noninvasive Evaluation for Possible Coronary Artery Disease: Insights From the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial..  5:193-201. 2020
  • Does Guideline-Directed Medical Therapy for Heart Failure Offer Benefits After LVAD Placement?-A Call for a Randomized Clinical Trial..  5:183. 2020
  • Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial..  5:202-207. 2020
  • Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older-Reply..  5:235-236. 2020
  • Temporal Trends in Racial Differences in 30-Day Readmission and Mortality Rates After Acute Myocardial Infarction Among Medicare Beneficiaries..  5:136-145. 2020
  • Clinical Considerations Prior to Transition From Triple Antithrombotic Therapy to Dual Antithrombotic Therapy-Reply..  5:111-112. 2020
  • Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review..  4:1287-1295. 2019
  • Logistical Challenges Associated With Implementing Precision Medicine-Reply..  4:1301. 2019
  • Postoperative and Nonvalvular Atrial Fibrillation-Not So Different After All..  4:1147-1148. 2019
  • Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk..  4:969-977. 2019
  • Current Demographic Status of Cardiologists in the United States..  4:1029-1033. 2019
  • Proposed Framework for the Optimal Measurement of Quality Assessment in Percutaneous Coronary Intervention..  4:963-964. 2019
  • Association of Daytime and Nighttime Blood Pressure With Cardiovascular Disease Events Among African American Individuals..  4:910-917. 2019
  • Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial..  4:857-864. 2019
  • Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness..  4:928-935. 2019
  • Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial..  4:846-854. 2019
  • Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation..  4:756-764. 2019
  • Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program..  4:727-735. 2019
  • Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials..  4:747-755. 2019
  • Effect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil: The BRIDGE Cardiovascular Prevention Cluster Randomized Clinical Trial..  4:408-417. 2019
  • Quantifying the Treatment Effect of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy-Reply..  4:494-495. 2019
  • Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States..  4:444-453. 2019
  • Evaluation of Mortality Data From the Social Security Administration Death Master File for Clinical Research..  4:375-379. 2019
  • Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial..  4:273-286. 2019
  • Prognostic Value of Vasodilator Stress Cardiac Magnetic Resonance Imaging: A Multicenter Study With 48 000 Patient-Years of Follow-up..  4:256-264. 2019
  • What Is Needed Now to Improve Cardiovascular Clinical Registries in the Future..  4:201-202. 2019
  • Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry..  4:110-118. 2019
  • Improving Value-Based Care for Left Ventricular Assist Device Therapy: Lowering Costs When Stakes Are High..  4:161-162. 2019
  • Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial..  4:7-15. 2019
  • Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II..  3:1174-1182. 2018
  • Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry..  3:1151-1159. 2018
  • Electrocardiography Screening for Atrial Fibrillation: We Can Do Better..  3:1144-1145. 2018
  • Errors in Programming and Coding Affecting Cohorts Included in the Study Deriving and Validating the PROMISE Minimal-Risk Tool..  3:1253-1254. 2018
  • Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences..  3:1192-1199. 2018
  • Role Models, Allies, and Diversity-Global Issues for Female Cardiology Trainees-Reply..  3:1252. 2018
  • Association of Same-Day Discharge After Elective Percutaneous Coronary Intervention in the United States With Costs and Outcomes..  3:1041-1049. 2018
  • Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy: A Meta-analysis..  3:1050-1059. 2018
  • Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial..  3:1113-1118. 2018
  • Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals..  3:929-938. 2018
  • Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials: A Systematic Review..  3:1011-1019. 2018
  • Tools for Evaluating and Improving Causal Inference: Introducing JAMA Cardiology Readers to the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) Tool..  3:907. 2018
  • Trends in Hospice Discharge and Relative Outcomes Among Medicare Patients in the Get With The Guidelines-Heart Failure Registry..  3:917-926. 2018
  • Association of Interleukin 6 Receptor Variant With Cardiovascular Disease Effects of Interleukin 6 Receptor Blocking Therapy: A Phenome-Wide Association Study..  3:849-857. 2018
  • Finding Means to Fulfill the Societal and Academic Imperative for Open Data Access and Sharing..  3:793-794. 2018
  • Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry..  3:739-748. 2018
  • Career Preferences and Perceptions of Cardiology Among US Internal Medicine Trainees: Factors Influencing Cardiology Career Choice..  3:682-691. 2018
  • Management of Ventricular Arrhythmias and Sudden Cardiac Death Risk Associated With Cardiac Channelopathies..  3:775-776. 2018
  • Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population..  3:583-590. 2018
  • Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure: A Review..  3:650-658. 2018
  • When Low-Risk Atrial Fibrillation Is Not So Low Risk: Beast of Burden..  3:558-560. 2018
  • Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines-Heart Failure Registry..  3:489-497. 2018
  • Management of Ventricular Arrhythmias and Sudden Cardiac Death Risk Related to Ischemic and Nonischemic Cardiomyopathy..  3:541-542. 2018
  • Mass Customization, Ubiquitous Information, and Improvements to Health Outcomes in the United States..  3:365-366. 2018
  • The Burden of Cardiovascular Diseases Among US States, 1990-2016..  3:375-389. 2018
  • Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial..  3:391-399. 2018
  • Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysis..  3:234-241. 2018
  • Outpatient Worsening Heart Failure as a Target for Therapy: A Review..  3:252-259. 2018
  • Coronary Calcium Score and Cardiovascular Risk in Elderly Populations-Reply..  3:180-181. 2018
  • Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible Acute Coronary Syndrome..  3:104-111. 2018
  • Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial..  3:144-152. 2018
  • Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry Study..  3:54-63. 2018
  • Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure..  3:44-53. 2018
  • Association of Physical Activity With Risk of Major Cardiovascular Diseases in Chinese Men and Women..  2:1349-1358. 2017
  • Administrative Codes for Capturing In-Hospital Cardiac Arrest..  2:1275-1277. 2017
  • Association of Public Health Initiatives With Outcomes for Out-of-Hospital Cardiac Arrest at Home and in Public Locations..  2:1226-1235. 2017
  • Implantable Cardioverter Defibrillators for Nonischemic Cardiomyopathy-Reply..  2:1283-1284. 2017
  • Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial..  2:1197-1206. 2017
  • The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines..  2:1175-1176. 2017
  • When Should Patients Be Involved in Cardiovascular Clinical Trial Design?: Always, Early, and Often..  2:1269-1270. 2017
  • Association of Neighborhood Demographics With Out-of-Hospital Cardiac Arrest Treatment and Outcomes: Where You Live May Matter..  2:1110-1118. 2017
  • Incentivizing Transradial Access for Primary Percutaneous Coronary Intervention While Maintaining Timely Reperfusion..  2:1057-1058. 2017
  • Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy-Breakthrough in Low-Density Lipoprotein Cholesterol Lowering, Breakdown in Value..  2:1066-1068. 2017
  • SPECT, PET, and CTA-Acronyms or Better Imaging?.  2:1108-1109. 2017
  • Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies..  2:986-994. 2017
  • Comparative Outcomes After Percutaneous Coronary Intervention Among Black and White Patients Treated at US Veterans Affairs Hospitals..  2:967-975. 2017
  • Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial..  2:950-958. 2017
  • Myocardial Fibrosis in Duchenne and Becker Muscular Dystrophy-Reply..  2:1046. 2017
  • Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice..  2:1040-1042. 2017
  • Outcomes Associated With Subcutaneous Implantable Cardioverter Defibrillators-Reply..  2:925-926. 2017
  • Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry..  2:846-854. 2017
  • Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS Study..  2:750-757. 2017
  • Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines..  2:723-731. 2017
  • Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial..  2:759-766. 2017
  • Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease..  2:635-643. 2017
  • Heterogeneity in Blood Pressure Transitions Over the Life Course: Age-Specific Emergence of Racial/Ethnic and Sex Disparities in the United States..  2:653-661. 2017
  • Integrating Research With Clinical Practice: Keeping It Simple..  2:616. 2017
  • Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis..  2:685-688. 2017
  • Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study..  2:644-652. 2017
  • Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial..  2:525-534. 2017
  • Heart Failure With Reduced Ejection Fraction in Human Immunodeficiency Virus Infection: The More Things Stay the Same..  2:476-477. 2017
  • Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial..  2:547-555. 2017
  • Value of Cardiovascular Magnetic Resonance Imaging-Derived Baseline Left Ventricular Ejection Fraction and Volumes for Precise Risk Stratification of Patients With Ischemic Cardiomyopathy: Insights From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial..  2:577-579. 2017
  • Assessing the Utility of Transcatheter Aortic Valve Replacement..  2:416-417. 2017
  • Identification of Patients With Stable Chest Pain Deriving Minimal Value From Noninvasive Testing: The PROMISE Minimal-Risk Tool, A Secondary Analysis of a Randomized Clinical Trial..  2:400-408. 2017
  • Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry..  2:409-416. 2017
  • Racial Differences in Associations of Blood Pressure Components in Young Adulthood With Incident Cardiovascular Disease by Middle Age: Coronary Artery Risk Development in Young Adults (CARDIA) Study..  2:381-389. 2017
  • Ongoing Management of Patients With Supraventricular Tachycardia..  2:332-333. 2017
  • Quality of Evidence Underlying the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines on the Management of Atrial Fibrillation..  2:319-323. 2017
  • The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review..  2:324-331. 2017
  • Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program..  2:136-145. 2017
  • Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial..  2:190-199. 2017
  • Prediction of 30-Day All-Cause Readmissions in Patients Hospitalized for Heart Failure: Comparison of Machine Learning and Other Statistical Approaches..  2:204-209. 2017
  • Resting Heart Rate and Long-term Outcomes Among the African American Population: Insights From the Jackson Heart Study..  2:172-180. 2017
  • Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men-Reply..  2:108-110. 2017
  • Intensive Care Unit Utilization and Mortality Among Medicare Patients Hospitalized With Non-ST-Segment Elevation Myocardial Infarction..  2:36-44. 2017
  • Making Every Mobile Heart Count!.  2:78. 2017
  • Who Belongs in the Cardiac Intensive Care Unit?.  2:45-46. 2017
  • Do Not Over (P) Value Your Research Article..  1:1055. 2016
  • Risk Prediction With Electronic Health Records: The Importance of Model Validation and Clinical Context..  1:976-977. 2016
  • Same-Day Discharge After Percutaneous Coronary Intervention-Reply..  1:1080. 2016
  • Understanding the Role of P Values and Hypothesis Tests in Clinical Research..  1:1048-1054. 2016
  • Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment..  1:864-871. 2016
  • Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less..  1:945-949. 2016
  • The US Food and Drug Administration and the Future of Cardiovascular Medicine..  1:950-952. 2016
  • Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States..  1:900-911. 2016
  • The Need to Improve Care and Research on Sexual Functioning in Cardiology..  1:765-766. 2016
  • Treatment, Outcomes, and Adherence to Medication Regimens Among Dual Medicare-Medicaid-Eligible Adults With Myocardial Infarction..  1:787-794. 2016
  • Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial..  1:673-681. 2016
  • Population Effect of Differences in Cholesterol Guidelines in Eastern Europe and the United States..  1:700-707. 2016
  • Potential Mortality Reduction With Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure..  1:714-717. 2016
  • Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study..  1:548-556. 2016
  • Evaluation of Flow After Transcatheter Aortic Valve Replacement in Patients With Low-Flow Aortic Stenosis: A Secondary Analysis of the PARTNER Randomized Clinical Trial..  1:584-592. 2016
  • Acute Treatment of Patients With Supraventricular Tachycardia..  1:483-485. 2016
  • Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Randomized Clinical Trial..  1:451-460. 2016
  • Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals..  1:442-450. 2016
  • Risk of Premature Cardiovascular Disease vs the Number of Premature Cardiovascular Events..  1:492-494. 2016
  • Understanding the Adverse Effects of Ticagrelor in Practice..  1. 2016
  • Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry..  1:282-291. 2016
  • Gait Speed and Operative Mortality in Older Adults Following Cardiac Surgery..  1:314-321. 2016
  • Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial..  1:126-135. 2016
  • Effect of the Presence and Type of Angina on Cardiovascular Events in Patients Without Known Coronary Artery Disease Referred for Elective Coronary Angiography..  1:232-234. 2016
  • Same-Day Discharge After Percutaneous Coronary Intervention: Current Perspectives and Strategies for Implementation..  1:216-223. 2016
  • The Enigma of Glucose and Lipid Metabolism..  1:145-146. 2016
  • Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction..  1:147-155. 2016
  • Using Data to Guide Anticoagulation in Patients With Atrial Fibrillation: Does the Analysis Fit the Question?.  1:121-122. 2016
  • Association Between Hospital Process Composite Performance and Patient Outcomes After In-Hospital Cardiac Arrest Care..  1:37-45. 2016
  • Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort..  1:15-25. 2016
  • Development and Validation of a Risk Prediction Model for In-Hospital Mortality After Transcatheter Aortic Valve Replacement..  1:46-52. 2016
  • Preventing Stroke in Patients With Atrial Fibrillation-A Steep Climb Away From Achieving Peak Performance..  1:63-64. 2016
  • Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome..  1:73-79. 2016
  • P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes. 2019